Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study
AffiliationDepartment of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, M6 8HD
MetadataShow full item record
AbstractBackground: Urological malignancy (UM) in patients with chronic kidney disease (CKD) is an added burden to their overall morbidity and mortality. UM is itself a common cause of CKD. Understanding the associations of UM with outcomes in advanced CKD can help in optimisation of the management of these patients. This study investigates the distribution and association of urological malignancy with outcomes (renal progression and mortality) in patients with advanced non-dialysis dependent CKD. Methods: The study was conducted in 2637 of 3115 patients recruited in the Salford Kidney Study between the years 2002 and 2016. A comparative analysis was performed between 160 patients with UM (at baseline and incident) and 2477 patients with no malignancy. Cox-regression models and Kaplan-Meir estimates were used to explore the association between the presence of UM with mortality and renal outcome. Linear regression analysis was used to calculate the rate of progression of CKD in the groups. A 1:3 propensity score matched cohort of 640 patients was generated and utilised in the above analyses. Results: 4.4% had a history of UM at baseline with the annual incident rate being 0.37%. The site of malignancy was the kidney in 40% with comparable numbers for prostatic malignancy (39%). 70% (111/160) of UM patients had a medical cause as their primary diagnosis for CKD. Over a median follow up of 4 years, 34% (905) patients died. In the matched sample, the proportion of deaths was similar between the groups (UM 44% versus no malignancy 48%, p = 0.36). 30% reached end-stage renal disease (ESRD) with no difference between the groups. In the Cox-regression model, UM did not prove to be a risk factor associated with either all-cause mortality (HR:1.03; CI: 0.79-1.35; p = 0.81) or reaching ESRD (HR:1.12; CI: 0.80-1.58; p = 0.49). The rate of decline in estimated glomerular filtration rate (eGFR) was similar between the groups (- 1.05 vs - 1.25 mL/min/1.73m2/year, p = 0.31). Conclusions: There was no correlation observed between UM and all-cause mortality or ESRD. Medical causes of CKD have a significant influence on the outcomes in patients with UM, whereas the UM did not. Hence, a coordinated approach with early liaison between the urology and nephrology teams is needed in the management of UM patients with CKD.
CitationChinnadurai R, Clarke NW, Kalra PA. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study. BMC Nephrol. 2020;21(1):202.
- Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
- Authors: Chinnadurai R, Flanagan E, Jayson GC, Kalra PA
- Issue date: 2019 Oct 22
- Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
- Authors: Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A, EuroSIDA in EuroCoord.
- Issue date: 2013 Sep
- Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
- Authors: Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH, Jummaat F
- Issue date: 2017 Jan
- Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
- Authors: Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS
- Issue date: 2018 Mar
- Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.
- Authors: Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, He J, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY, CRIC Study Investigators.
- Issue date: 2018 May